Giri Devanur
CIK 1643490 · Executive Chairman · last filed 2026-08-13
Giri Devanur is an Executive Chairman who has filed 14 SEC Form 4 insider transactions across 3 companies since 2017. The most recent filing shows the insider sold $3.1K of AIRE on Aug 13, 2026. Across all open-market trades the lifetime net is −$841.1K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.7M across reported positions. 3 SEC filings were submitted jointly with BHAV Partners LLC.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
AMRHW price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
PRINCETON, NJ 08540
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AIRE | Executive Chairman | 1,199,645 | $1.12 | $1.34M | -$3.1K | 10 | 2026-08-13 |
| BHAVU | CEO and Director | 135,000 | $10.15 | $1.37M | $0 | 1 | 2026-03-20 |
| Enveric Biosciences, Inc. (AMRHW) Delisted | President & CEO | 1,861,989 | — | — | -$838.1K | 2 | 2018-07-19 |
Recent Filings
14 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-08-13 | AIRE | Sell (S) | −1,999 | -$3.1K | EDGAR |
| 2026-08-03 | AIRE | Grant (A) | +43,580 | $0 | EDGAR |
| 2026-07-29 | AIRE | Tax (F) | −1,051 | -$1.5K | EDGAR |
| 2026-05-04 | AIRE | Grant (A) | +13,323 | $0 | EDGAR |
| 2026-03-20 | BHAVU | Buy (P) | +270,000 | $0 | EDGAR |
| 2026-02-03 | AIRE | Grant (A) | +414,230 | $0 | EDGAR |
| 2025-11-03 | AIRE | — | — | $0 | EDGAR |
| 2025-11-03 | AIRE | Grant (A) | +149,133 | $0 | EDGAR |
| 2025-11-03 | AIRE | — | — | $0 | EDGAR |
| 2025-08-01 | AIRE | Grant (A) | +265,341 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.